We're thrilled to announce the launch of our groundbreaking clinical trial, MICRO2, which aims to validate early evidence demonstrating MCG’s ability to aid in the noninvasive diagnosis of Coronary Microvascular Dysfunction.
https://t.co/99xMuaa6eu
Today, the Genetesis team wore red in honor of the many women who struggle with heart disease across the country and around the world.
We're motivated and proud to play our own small role in helping address this critical gap in patient care.
#HeartMonth2024
Another work from my PhD with @CampbellLabatUK is just published in Computers in Biology and Medicine.
In this study:
1) We illustrated how to integrate the effects of the #baroreceptors reflex loop 🧠 into the FE modeling of #cardiac#mechanics.
https://t.co/khwhnCiJoM
2) We demonstrated how the influence of baroreceptor reflex loop is important in maintaining arterial #BloodPressure, as observed in simulations of valvular diseases including #AorticStenosis and #MitralRegurgitation.
The are still 2 days left to register for the next #LivingHeartProject webinar on Feb 8th.
This work has been done as a collaboration between Dr. Wenk and @CampbellLabatUK from #UKY and Dr. Lee from #MSU.
Do you want to hear more about the multiscale modeling of #cardiac growth? Make sure you register for the next LHP webinar where I will talk about my #PhD research entitled "Multiscale modeling of LV #growth in simulations of valve disease"
https://t.co/2aQSUVjChn
Do you want to hear more about the multiscale modeling of #cardiac growth? Make sure you register for the next LHP webinar where I will talk about my #PhD research entitled "Multiscale modeling of LV #growth in simulations of valve disease"
https://t.co/2aQSUVjChn
Updated BioRxiv preprint with our latest simulations demonstrating closed loop baroreflex control of arterial pressure - with @Sharifi_UKY
https://t.co/Gqi5JG8iXK